Literature DB >> 32550982

Cancer Immunotherapy through the Inhibition of Diacylglycerol Kinases Alpha and Zeta.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2020        PMID： 32550982      PMCID： PMC7294543          DOI： 10.1021/acsmedchemlett.0c00118

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  Immune checkpoint blockade opens a new way to cancer immunotherapy.

Authors:  Sanam Sadreddini; Behzad Baradaran; Ali Aghebati-Maleki; Sevil Sadreddini; Dariush Shanehbandi; Ali Fotouhi; Leili Aghebati-Maleki
Journal:  J Cell Physiol       Date:  2018-12-03       Impact factor: 6.384

Review 2.  Diacylglycerol kinases in cancer.

Authors:  Isabel Mérida; Pedro Torres-Ayuso; Antonia Ávila-Flores; Javier Arranz-Nicolás; Elena Andrada; María Tello-Lafoz; Rosa Liébana; Raquel Arcos
Journal:  Adv Biol Regul       Date:  2016-09-23
  2 in total
  1 in total

Review 1.  Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.

Authors:  Suresh Velnati; Sara Centonze; Federico Girivetto; Gianluca Baldanzi
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.